Four months of rifampicin for tuberculosis prevention treatment in children

被引：0
|
作者：
Trajman, Anete [1 ,2 ]
Diallo, Thierno [3 ]
Menzies, Dick [2 ,4 ]
机构：
[1] Univ Fed Rio de Janeiro, Dept Internal Med, Rio de Janeiro, Brazil
[2] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada
[3] Univ Gamal Abdel Nasser Conakry, Serv Pneumophtisiol, Hop Natl Ignace Deen, Conakry, Guinea
[4] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada
来源：
JOURNAL OF INFECTION AND CHEMOTHERAPY | 2023年 / 29卷 / 02期
关键词：
LATENT TUBERCULOSIS;
D O I：
10.1016/j.jiac.2022.10.016
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [21] Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak
    Lee, S. H.
    Yim, J. -J.
    Kim, H. J.
    Shim, T. S.
    Seo, H. S.
    Cho, Y. S.
    Lee, H. -K.
    Lee, Y. M.
    Lee, E. J.
    Lew, W. J.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (06): : 1028 - 1035
  • [22] RIFAMPICIN AND ISONIAZID MICROCAPSULES FOR TREATMENT OF TUBERCULOSIS
    Shrikhande, S. S.
    Bajaj, A.
    Pinto, B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (01): : 281 - 287
  • [23] Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population
    Jimenez-Fuentes, M. A.
    de Souza-Galvao, M. L.
    Mila Auge, C.
    Solsona Peiro, J.
    Altet-Gomez, M. N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (03) : 326 - 332
  • [24] HEPATOTOXICITY OF RIFAMPICIN AND ISONIAZID IN CHILDREN TREATED FOR TUBERCULOSIS
    LINNA, O
    UHARI, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1980, 134 (03) : 227 - 229
  • [25] Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children
    Radtke, Kendra K.
    Hesseling, Anneke C.
    Winckler, J. L.
    Draper, Heather R.
    Solans, Belen P.
    Thee, Stephanie
    Wiesner, Lubbe
    van der Laan, Louvina E.
    Fourie, Barend
    Nielsen, James
    Schaaf, H. Simon
    Savic, Radojka M.
    Garcia-Prats, Anthony J.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (08) : 1372 - 1381
  • [26] Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis
    Garcia-Prats, Anthony J.
    Hoddinott, Graeme
    Howell, Pauline
    Hughes, Jennifer
    Jean-Philippe, Patrick
    Kim, Soyeon
    Palmer, Megan
    Schaaf, H. Simon
    Seddon, James A.
    Svensson, Elin
    Hesseling, Anneke C.
    LANCET INFECTIOUS DISEASES, 2023, 23 (07):
  • [27] A THERAPEUTIC TRIAL OF THE COMBINATION OF ISONIAZID, RIFAMPICIN AND PYRAZINAMIDE IN THE 1ST 2 MONTHS OF TREATMENT FOR PULMONARY TUBERCULOSIS
    BELLABAS, M
    KHALED, S
    KHALED, NA
    BOULAHBAL, F
    CHAULET, P
    REVUE DES MALADIES RESPIRATOIRES, 1989, 6 (01) : 59 - 64
  • [28] Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
    Menzies, D.
    Adjobimey, M.
    Ruslami, R.
    Trajman, A.
    Sow, O.
    Kim, H.
    Baah, J. Obeng
    Marks, G. B.
    Long, R.
    Hoeppner, V.
    Elwood, K.
    Al-Jahdali, H.
    Gninafon, M.
    Apriani, L.
    Koesoemadinata, R. C.
    Kritski, A.
    Rolla, V.
    Bah, B.
    Camara, A.
    Boakye, I.
    Cook, V. J.
    Goldberg, H.
    Valiquette, C.
    Hornby, K.
    Dion, M. -J.
    Li, P. -Z.
    Hill, P. C.
    Schwartzman, K.
    Benedetti, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 440 - 453
  • [29] RIFAMPICIN IN TREATMENT OF PREVIOUSLY UNTREATED PULMONARY TUBERCULOSIS
    ORLOWSKI, EH
    RESPIRATION, 1971, 28 : 100 - &
  • [30] Changing the treatment landscape for latent tuberculosis with rifampicin
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2018, 6 (10): : 740 - 740
12345